MYB and adrenal cortex carcinoma: In vitro immunohistochemical analysis of both fusion-positive and fusion-negative human ACC tissue samples performed using a monoclonal antibody against the N-terminal domain of human MYB demonstrated strong nuclear staining for MYB in fusion-positive tumors (85%) but also in fusion-negative tumors (61%) [89].